{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:12:16Z","timestamp":1794654736523,"version":"4.9.1"},"reference-count":79,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1084230"],"award-info":[{"award-number":["APP1084230"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Sarcoma Study Group","award":["Johanna Sewell Research Grant"],"award-info":[{"award-number":["Johanna Sewell Research Grant"]}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","award":["APP1047593"],"award-info":[{"award-number":["APP1047593"]}],"id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer Therapeutics CRC PhD Scholarship"},{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","award":["Operational Infrastructure Support Scheme"],"award-info":[{"award-number":["Operational Infrastructure Support Scheme"]}],"id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000926","name":"Leukaemia Foundation","doi-asserted-by":"publisher","award":["Phillip Desbrow Senior Research Fellowship"],"award-info":[{"award-number":["Phillip Desbrow Senior Research Fellowship"]}],"id":[{"id":"10.13039\/501100000926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP559016"],"award-info":[{"award-number":["APP559016"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["Mid Career Research Fellowship MCRF15015"],"award-info":[{"award-number":["Mid Career Research Fellowship MCRF15015"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Mutations in the P53 pathway are a hallmark of human cancer. The identification of pathways upon which p53-deficient cells depend could reveal therapeutic targets that may spare normal cells with intact p53. In contrast to P53 point mutations in other cancer, complete loss of P53 is a frequent event in osteosarcoma (OS), the most common cancer of bone. The consequences of p53 loss for osteoblastic cells and OS development are poorly understood. Here we use murine OS models to demonstrate that elevated Pthlh (Pthrp), cAMP levels and signalling via CREB1 are characteristic of both p53-deficient osteoblasts and OS. Normal osteoblasts survive depletion of both PTHrP and CREB1. In contrast, p53-deficient osteoblasts and OS depend upon continuous activation of this pathway and undergo proliferation arrest and apoptosis in the absence of PTHrP or CREB1. Our results identify the PTHrP-cAMP-CREB1 axis as an attractive pathway for therapeutic inhibition in OS.<\/jats:p>","DOI":"10.7554\/elife.13446","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T07:29:18Z","timestamp":1460186958000},"source":"Crossref","is-referenced-by-count":48,"title":["Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance"],"prefix":"10.7554","volume":"5","author":[{"given":"Mannu K","family":"Walia","sequence":"first","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia MW","family":"Ho","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Taylor","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin JM","family":"Ng","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"},{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Gupte","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair M","family":"Chalk","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"},{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew CW","family":"Zannettino","sequence":"additional","affiliation":[{"name":"Myeloma Research Laboratory, School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia"},{"name":"Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T John","family":"Martin","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"},{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9031","authenticated-orcid":true,"given":"Carl R","family":"Walkley","sequence":"additional","affiliation":[{"name":"St. Vincent's Institute of Medical Research, Fitzroy, Australia"},{"name":"Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Australia"},{"name":"ACRF Rational Drug Discovery Centre, St. Vincent\u2019s Institute of Medical Research, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1359\/jbmr.080324","article-title":"Ephrinb2 regulation by PTH and pthrp revealed by molecular profiling in differentiating osteoblasts","volume":"23","author":"Allan","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S8756-3282(02)00858-X","article-title":"Human osteoblasts are resistant to apo2l\/trail-mediated apoptosis","volume":"31","author":"Atkins","year":"2002","journal-title":"Bone"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1038\/srep10120","article-title":"Bet inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells","volume":"5","author":"Baker","year":"2015","journal-title":"Scientific Reports"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"Berger","year":"2012","journal-title":"Nature"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/onc.2014.41","article-title":"Pka signaling drives mammary tumorigenesis through src","volume":"34","author":"Beristain","year":"2015","journal-title":"Oncogene"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1073\/pnas.0805462105","article-title":"Metastatic osteosarcoma induced by inactivation of rb and p53 in the osteoblast lineage","volume":"105","author":"Berman","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tcb.2011.10.006","article-title":"Deconstructing p53 transcriptional networks in tumor suppression","volume":"22","author":"Bieging","year":"2012","journal-title":"Trends in Cell Biology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Bieging","year":"2014","journal-title":"Nature Reviews. Cancer"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1038\/ncomms4756","article-title":"Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden","volume":"5","author":"Cazier","year":"2014","journal-title":"Nature Communications"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"Chen","year":"2014","journal-title":"Cell Reports"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1093\/nar\/gkp507","article-title":"Detection of single nucleotide variations in expressed exons of the human genome using rna-seq","volume":"37","author":"Chepelev","year":"2009","journal-title":"Nucleic Acids Research"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"Pth and pthrp signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cellular Signalling"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours","volume":"356","author":"Donehower","year":"1992","journal-title":"Nature"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature11143","article-title":"Whole-genome analysis informs breast cancer response to aromatase inhibition","volume":"486","author":"Ellis","year":"2012","journal-title":"Nature"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/s1043-2760(01)00409-x","article-title":"Molecular properties of the pth\/pthrp receptor","volume":"12","author":"Gardella","year":"2001","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer","volume":"223","author":"Goh","year":"2011","journal-title":"The Journal of Pathology"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1158\/1078-0432.CCR-14-3026","article-title":"Systematic screening identifies dual PI3K and mtor inhibition as a conserved therapeutic vulnerability in osteosarcoma","volume":"21","author":"Gupte","year":"2015","journal-title":"Clinical Cancer Research"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/s1097-2765(00)80468-2","article-title":"Distinct roles for CTD ser-2 and ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mrna capping enzyme","volume":"3","author":"Ho","year":"1999","journal-title":"Molecular Cell"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1038\/onc.2014.217","article-title":"Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo","volume":"34","author":"Ho","year":"2015","journal-title":"Oncogene"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1239278","article-title":"Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds","volume":"341","author":"Hou","year":"2013","journal-title":"Science"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1002\/cncr.27414","article-title":"Outcome for adolescent and young adult patients with osteosarcoma: A report from the children's oncology group","volume":"118","author":"Janeway","year":"2012","journal-title":"Cancer"},{"key":"bib23","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1016\/S0021-9258(18)68339-5","article-title":"The parathyroid hormone-like peptide associated with humoral hypercalcemia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17\/2.8 cells","volume":"263","author":"J\u00fcppner","year":"1988","journal-title":"The Journal of Biological Chemistry"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"R132","DOI":"10.1186\/gb-2013-14-12-r132","article-title":"Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A\/B","volume":"14","author":"Karlsson","year":"2013","journal-title":"Genome Biology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1101\/gad.212282.112","article-title":"Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses","volume":"27","author":"Kenzelmann Broz","year":"2013","journal-title":"Genes & Development"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nrd4288","article-title":"Drugging the p53 pathway: Understanding the route to clinical efficacy","volume":"13","author":"Khoo","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-010-0798-y","article-title":"Pka-induced phosphorylation of er\u03b1 at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in er-positive breast cancer","volume":"125","author":"Kok","year":"2011","journal-title":"Breast Cancer Research and Treatment"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: Precision weights unlock linear model analysis tools for rna-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biology"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"32976","DOI":"10.1074\/jbc.M111.218016","article-title":"Transcriptional control of adrenal steroidogenesis: Novel connection between janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of camp response element-binding protein (CREB) transcription factor","volume":"286","author":"Lefrancois-Martinez","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1083\/jcb.200508130","article-title":"Osteoblast differentiation and skeletal development are regulated by mdm2-p53 signaling","volume":"172","author":"Lengner","year":"2006","journal-title":"The Journal of Cell Biology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/260436a0","article-title":"Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma","volume":"260","author":"Martin","year":"1976","journal-title":"Nature"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1749-6632.2002.tb04325.x","article-title":"Regulatory subunits of PKA and breast cancer","volume":"968","author":"Miller","year":"2002","journal-title":"Annals of the New York Academy of Sciences"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng882","article-title":"Disruption of CREB function in brain leads to neurodegeneration","volume":"31","author":"Mantamadiotis","year":"2002","journal-title":"Nature Genetics"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1172\/JCI26239","article-title":"Osteoblast-derived pthrp is a physiological regulator of bone formation","volume":"115","author":"Martin","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"bib36","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00031.2015","article-title":"Parathyroid hormone-related protein, its regulation of cartilage and bone development and role in treating bone diseases","author":"Martin","year":"2016","journal-title":"Physiological Reviews"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"Mayr","year":"2001","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/jbmr.1617","article-title":"Twenty-five years of pthrp progress: From cancer hormone to multifunctional cytokine","volume":"27","author":"McCauley","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1172\/JCI24918","article-title":"Osteoblast-derived pthrp is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34","volume":"115","author":"Miao","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"International Journal of Cancer"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7085","article-title":"Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters","author":"Mitton","year":"2016","journal-title":"Oncotarget"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1172\/JCI42391","article-title":"Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice","volume":"120","author":"Molyneux","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ng.3293","article-title":"A sleeping beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis","volume":"47","author":"Moriarity","year":"2015","journal-title":"Nature Genetics"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large b-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","article-title":"Crebbp mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bone.2013.02.016","article-title":"Modeling distinct osteosarcoma subtypes in vivo using cre:lox and lineage-restricted transgenic shrna","volume":"55","author":"Mutsaers","year":"2013","journal-title":"Bone"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bone.2014.02.003","article-title":"Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?","volume":"62","author":"Mutsaers","year":"2014","journal-title":"Bone"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"e1005160","DOI":"10.1371\/journal.pgen.1005160","article-title":"The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation","volume":"11","author":"Ng","year":"2015","journal-title":"PLoS Genetics"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"Tp53 mutations in human cancers: Origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"bib50","first-page":"2665","article-title":"Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy","volume":"24","author":"Onuma","year":"2004","journal-title":"Anticancer Research"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/endo-108-1-220","article-title":"Activation of adenosine 3',5'-monophosphate-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2, and prostacyclin","volume":"108","author":"Partridge","year":"1981","journal-title":"Endocrinology"},{"key":"bib52","first-page":"4308","article-title":"Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin","volume":"43","author":"Partridge","year":"1983","journal-title":"Cancer Research"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"aad3680","DOI":"10.1126\/science.aad3680","article-title":"Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability","volume":"351","author":"Pattabiraman","year":"2016","journal-title":"Science"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"E5564","DOI":"10.1073\/pnas.1419260111","article-title":"Complementary genomic approaches highlight the pi3k\/mtor pathway as a common vulnerability in osteosarcoma","volume":"111","author":"Perry","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3324\/haematol.2012.070664","article-title":"Microrna-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation","volume":"98","author":"Pigazzi","year":"2013","journal-title":"Haematologica"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1073\/pnas.0801027105","article-title":"Molecular recognition of parathyroid hormone by its G protein-coupled receptor","volume":"105","author":"Pioszak","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/onc.2014.354","article-title":"The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse","volume":"34","author":"Quist","year":"2015","journal-title":"Oncogene"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1038\/sj.emboj.7601715","article-title":"Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression","volume":"26","author":"Ravnskjaer","year":"2007","journal-title":"The EMBO Journal"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.18632\/oncotarget.3115","article-title":"Tp53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause li-fraumeni syndrome","volume":"6","author":"Ribi","year":"2015","journal-title":"Oncotarget"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nmeth.2212","article-title":"A travel guide to cytoscape plugins","volume":"9","author":"Saito","year":"2012","journal-title":"Nature Methods"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1182\/blood-2011-05-357418","article-title":"Sox4 cooperates with CREB in myeloid transformation","volume":"120","author":"Sandoval","year":"2012","journal-title":"Blood"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/ng.2645","article-title":"Genome-wide association study identifies two susceptibility loci for osteosarcoma","volume":"45","author":"Savage","year":"2013","journal-title":"Nature Genetics"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1182\/blood-2004-01-0272","article-title":"G-CSF potently inhibits osteoblast activity and CXCL12 mrna expression in the bone marrow","volume":"106","author":"Semerad","year":"2005","journal-title":"Blood"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ccr.2005.02.018","article-title":"The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia","volume":"7","author":"Shankar","year":"2005","journal-title":"Cancer Cell"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Research"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1182\/blood-2010-11-320564","article-title":"Erythropoietin couples erythropoiesis, b-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment","volume":"117","author":"Singbrant","year":"2011","journal-title":"Blood"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3324\/haematol.2013.093971","article-title":"The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease","volume":"99","author":"Singbrant","year":"2014","journal-title":"Haematologica"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1182\/blood-2004-01-0240","article-title":"The phosphodiesterase PDE4B limits camp-associated pi3k\/akt-dependent apoptosis in diffuse large b-cell lymphoma","volume":"105","author":"Smith","year":"2005","journal-title":"Blood"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1359\/jbmr.2002.17.8.1401","article-title":"Induction of transcriptional activity of the cyclic adenosine monophosphate response element binding protein by parathyroid hormone and epidermal growth factor in osteoblastic cells","volume":"17","author":"Swarthout","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1038\/ncomms6812","article-title":"Genome-wide analysis of the human p53 transcriptional network unveils a lncrna tumour suppressor signature","volume":"5","author":"S\u00e1nchez","year":"2014","journal-title":"Nature Communications"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ccr.2014.07.023","article-title":"Notch activation as a driver of osteogenic sarcoma","volume":"26","author":"Tao","year":"2014","journal-title":"Cancer Cell"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode","year":"2014","journal-title":"Cancer Discovery"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicologic Pathology"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1101\/gad.1656808","article-title":"Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of rb, mimics the human disease","volume":"22","author":"Walkley","year":"2008","journal-title":"Genes & Development"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.200507106","article-title":"p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling","volume":"172","author":"Wang","year":"2006","journal-title":"The Journal of Cell Biology"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1021\/acs.jmedchem.5b00468","article-title":"Identification of a potent inhibitor of creb-mediated gene transcription with efficacious in vivo anticancer activity","volume":"58","author":"Xie","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ijc.22749","article-title":"Over-expression of parathyroid hormone type 1 receptor confers an aggressive phenotype in osteosarcoma","volume":"121","author":"Yang","year":"2007","journal-title":"International Journal of Cancer"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/onc.2014.429","article-title":"Nkd2, a negative regulator of wnt signaling, suppresses tumor growth and metastasis in osteosarcoma","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/13446\/elife-13446-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/13446\/elife-13446-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/13446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:48:59Z","timestamp":1697057339000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/13446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":79,"alternative-id":["10.7554\/eLife.13446"],"URL":"https:\/\/doi.org\/10.7554\/elife.13446","archive":["CLOCKSS"],"relation":{"references":[{"id-type":"uri","id":"https:\/\/www.ebi.ac.uk\/ega\/studies\/EGAS00001000263","asserted-by":"subject"},{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/projects\/gap\/cgi-bin\/study.cgi?study_id=phs000452.v2.p1&phv=167386&phd=&pha=&pht=2591&phvf=&phdf=&phaf=&phtf=&dssp=1&consent=&temp=1","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/ega-archive.org\/search-results.php?query=egas00001000738","asserted-by":"subject"},{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/projects\/gap\/cgi-bin\/dataset.cgi?study_id=phs000532.v5.p2&phv=173801&phd=&pha=&pht=2979&phvf=&phdf=&phaf=&phtf=&dssp=1&consent=&temp=1","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/ega-archive.org\/search-results.php?query=EGAS00001000855","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/ega-archive.org\/search-results.php?query=EGAS00001000839","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE29442","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE35191","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.13446.039","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.13446.040","asserted-by":"object"}],"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.008","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.009","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.010","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.011","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.012","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.013","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.014","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.015","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.016","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.017","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.018","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.019","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.020","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.021","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.022","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.039","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.7554\/elife.13446.040","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]},"article-number":"e13446"}}